Literature DB >> 14609612

Conversion of rheumatic atrial fibrillation by amiodarone after percutaneous balloon mitral commissurotomy.

Tsun-Jui Liu1, Chung-Whei Hsueh, Wen-Lieng Lee, Hui-Chin Lai, Kuo-Yang Wang, Chih-Tai Ting.   

Abstract

Amiodarone, used in conjunction with percutaneous balloon mitral commissurotomy, can safely convert rheumatic atrial fibrillation in 38% of patients compared with 0% in those without it. However, whether this treatment exerts long-term benefits on prognosis awaits further investigation.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14609612     DOI： 10.1016/j.amjcard.2003.07.045

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  3 in total

1.  A randomized placebo-controlled trial with amiodarone for persistent atrial fibrillation in rheumatic mitral stenosis after successful balloon mitral valvuloplasty.

Authors:  Vinoth Kumar Vilvanathan; Budunur C Srinivas Prabhavathi Bhat; Manjunath Cholenahally Nanjappa; Bharathi Pandian; Vithal Bagi; Sridhar Kasturi; Shiva Kumar Bandimida
Journal:  Indian Heart J       Date:  2016-04-20

2.  A pilot study on the acute conversion and maintenance of sinus rhythm in rheumatic atrial fibrillation using oral flecainide.

Authors:  Anindya Ghosh; Aditya Kapoor; Roopali Khanna; Ankit Sahu; Sudeep Kumar; Naveen Garg; Satyendra Tewari; Pravin Goel
Journal:  Indian Heart J       Date:  2020-07-14

3.  Evaluation of early direct current cardioversion for maintenance of sinus rhythm in rheumatic atrial fibrillation following successful balloon mitral valvotomy.

Authors:  Gautam Sharma; R Anantha Krishnan; Vijay Bohra; Sivasubramanian Ramakrishnan; Nitish Naik; Sandeep Seth; Rajnish Juneja; M Kalaivani; Vinay Kumar Bahl
Journal:  Indian Heart J       Date:  2016-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.